by Jason Heaviland | Feb 19, 2026
MassID is a computational tool that enables near-complete annotation of untargeted metabolomics datasets by assigning identification probabilities to detected features. Traditional workflows often leave many metabolites unannotated, limiting downstream biological...
by Jason Heaviland | Dec 3, 2025
From Metabolism to Mechanism, Profile PRMT5 Activity in Cancer Profile PRMT5 activity with precise SDMA/ADMA quantification and full methionine cycle coverage. Support inhibitor development, patient stratification, and tumor profiling.
by Jason Heaviland | Dec 2, 2025
Beyond Plaques and Tangles: How Untargeted Metabolomics Detects Distinct Signatures in Alzheimer’s Disease Untargeted metabolomics captures systemic metabolic changes in neurodegenerative diseases, such as Alzheimer’s, identifying altered pathways and...
by Jason Heaviland | Nov 21, 2025
Unlocking FFPE Archives: How TissueBridge™️ Enables Retrospective Profiling of Tumor Metabolism Panome Bio’s TissueBridge technology unlocks the full metabolomic potential of FFPE tissue archives, enabling comprehensive, high-confidence profiling of tumor metabolism...
by ODWAdmin | Sep 22, 2025
Comprehensive Biological Profiling in Cancer via Multi-Omics Integration Colorectal cancer is on the rise and remains difficult to detect and treat. Panome Bio’s multi-omics platform combines metabolomics and proteomics to reveal how molecules interact across...
